Evidence map›Paper›PMID 24839583›Full record

ArticleMedicinal chemistry2014

DNA Binding Polyamides and the Importance of DNA Recognition in their use as Gene-Specific and Antiviral Agents.

Kevin J Koeller, G Davis Harris, Karl Aston, Gaofei He, Carlos H Castaneda, Melissa A Thornton, Terri G Edwards, Shuo Wang, Rupesh Nanjunda, W David Wilson and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Medicinal chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kevin J KoellerDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St.Louis, MO 63121, USA.
G Davis HarrisDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St.Louis, MO 63121, USA.
Karl AstonDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St.Louis, MO 63121, USA.
Gaofei HeDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St.Louis, MO 63121, USA.
Carlos H CastanedaDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St.Louis, MO 63121, USA.
Melissa A ThorntonDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St.Louis, MO 63121, USA.
Terri G EdwardsNanoVir, LLC, Kalamazoo, MI 49008, USA.
Shuo WangDepartment of Chemistry, Georgia State University, Atlanta, GA 30303, USA.
Rupesh NanjundaDepartment of Chemistry, Georgia State University, Atlanta, GA 30303, USA.
W David WilsonDepartment of Chemistry, Georgia State University, Atlanta, GA 30303, USA.
Chris FisherNanoVir, LLC, Kalamazoo, MI 49008, USA.
James K BashkinDepartment of Chemistry & Biochemistry, University of Missouri-St. Louis, St.Louis, MO 63121, USA ; NanoVir, LLC, Kalamazoo, MI 49008, USA.
Georgia State University · US

Funding

Heterocycle Cation Recognition of the DNA Minor Groove.R01AI064200 · NIAID · GEORGIA STATE UNIVERSITY · PI WILSON, W DAVID · 2005 to 2014
$3.4M
Pre-clinical Development of a Broad Spectrum Antiviral Compound to Treat Human PaR42AI068159 · NIAID · NANOVIR, LLC. · PI FISHER, CHRISTOPHER · 2010 to 2012
$3.0M
Pre-Clinical HPV16 Antiviral Compound DevelopmentR42AI062182 · NIAID · NANOVIR, LLC. · PI FISHER, CHRISTOPHER · 2008 to 2010
$2.9M
Biophysics of Drug Interactions with Viral EpisomesR01AI083803 · NIAID · UNIVERSITY OF MISSOURI-ST. LOUIS · PI BASHKIN, JAMES K. · 2010 to 2014
$1.8M
Antiviral Compounds that Target HPV18 DNAR41AI068159 · NIAID · NANOVIR, LLC. · PI FISHER, CHRISTOPHER · 2007 to 2008
$979k
Antiviral Compounds for Human Papillomavirus 16R41AI062182 · NIAID · NANOVIR, LLC. · PI FISHER, CHRISTOPHER · 2004 to 2005
$771k
NIAID NIH HHS R01 AI064200NIAID NIH HHS R01 AI083803NIAID NIH HHS R41 AI062182NIAID NIH HHS R41 AI068159NIAID NIH HHS R42 AI062182NIAID NIH HHS R42 AI068159
6 · The paper itself

Abstract

There is a long history for the bioorganic and biomedical use of N-methyl-pyrrole-derived polyamides (PAs) that are higher homologs of natural products such as distamycin A and netropsin. This work has been pursued by many groups, with the Dervan and Sugiyama groups responsible for many breakthroughs. We have studied PAs since about 1999, partly in industry and partly in academia. Early in this program, we reported methods to control cellular uptake of polyamides in cancer cell lines and other cells likely to have multidrug resistance efflux pumps induced. We went on to discover antiviral polyamides active against HPV31, where SAR showed that a minimum binding size of about 10 bp of DNA was necessary for activity. Subsequently we discovered polyamides active against two additional high-risk HPVs, HPV16 and 18, a subset of which showed broad spectrum activity against HPV16, 18 and 31. Aspects of our results presented here are incompatible with reported DNA recognition rules. For example, molecules with the same cognate DNA recognition properties varied from active to inactive against HPVs. We have since pursued the mechanism of action of antiviral polyamides, and polyamides in general, with collaborators at NanoVir, the University of Missouri-St. Louis, and Georgia State University. We describe dramatic consequences of β-alanine positioning even in relatively small, 8-ring polyamides; these results contrast sharply with prior reports. This paper was originally presented by JKB as a Keynote Lecture in the 2

Identifiers

PMID24839583
PMCPMC4022477
OpenAlexW2105343917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.